Last reviewed · How we verify

NCT06164535

The Effects of DPPIs on Cognitive Function of Diabetic Patients

Status unknown Phase 4 Last updated 11 December 2023
What this trial tests

Phase 4 trial testing Control group in Cognitive Impairment in 105 participants. Status unknown.

Timeline
30 December 2023
Primary endpoint
30 June 2024
15 July 2024

Quick facts

Lead sponsorBeni-Suef University
PhasePhase 4
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment105
Start date30 December 2023
Primary completion30 June 2024
Estimated completion15 July 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Beni-Suef University

Who can join

Adults 45 to 60, any sex, with Cognitive Impairment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a single-center, randomized controlled clinical trial with a parallel-group design conducted at Minia University hospital.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Control group

Trials testing the same drug.

Other recruiting trials for Cognitive Impairment

Currently open trials in the same condition.

Other Beni-Suef University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06164535.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing